Russell Investments Group’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
8,672
+7,120
+459% +$149K ﹤0.01% 3142
2026
Q1
$30.9K Sell
1,552
-11
-0.7% -$259 ﹤0.01% 3484
2025
Q4
$41.5K Buy
1,563
+474
+44% +$12.2K ﹤0.01% 3368
2025
Q3
$25.9K Sell
1,089
-22,113
-95% -$395K ﹤0.01% 3517
2025
Q2
$385K Buy
23,202
+4,859
+26% +$106K ﹤0.01% 2442
2025
Q1
$457K Buy
+18,343
New +$421K ﹤0.01% 2327

Other funds holding KMTS

Russell Investments Group's KMTS Position: Q2 2026 in Review

Russell Investments Group increased its Kestra Medical Technologies (KMTS) stake by 459% in Q2 2026, buying an estimated $149K and bringing the position to 8,672 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

Russell Investments Group first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $457K in Q1 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Russell Investments Group held 8,672 shares of Kestra Medical Technologies worth $221K as of Q2 2026.
  • Russell Investments Group bought 7,120 Kestra Medical Technologies shares in Q2 2026, an estimated $149K.
  • Kestra Medical Technologies made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3142 holding.
  • Russell Investments Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Russell Investments Group's Kestra Medical Technologies position peaked at $457K in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.